198 related articles for article (PubMed ID: 18096680)
1. Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event.
van Wijk I; Koudstaal PJ; Kappelle LJ; van Gijn J; Gorter JW; Algra A;
J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):895-9. PubMed ID: 18096680
[TBL] [Abstract][Full Text] [Related]
2. Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group.
Koudstaal PJ; Algra A; Pop GA; Kappelle LJ; van Latum JC; van Gijn J
Lancet; 1992 Sep; 340(8820):630-3. PubMed ID: 1355211
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study.
van Wijk I; Kappelle LJ; van Gijn J; Koudstaal PJ; Franke CL; Vermeulen M; Gorter JW; Algra A;
Lancet; 2005 Jun 18-24; 365(9477):2098-104. PubMed ID: 15964446
[TBL] [Abstract][Full Text] [Related]
4. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group.
Lancet; 1993 Nov; 342(8882):1255-62. PubMed ID: 7901582
[TBL] [Abstract][Full Text] [Related]
5. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
[TBL] [Abstract][Full Text] [Related]
6. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
[TBL] [Abstract][Full Text] [Related]
8. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
Atanassova PA; Chalakova NT; Dimitrov BD
Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
[TBL] [Abstract][Full Text] [Related]
9. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial.
Diener HC; Connolly SJ; Ezekowitz MD; Wallentin L; Reilly PA; Yang S; Xavier D; Di Pasquale G; Yusuf S;
Lancet Neurol; 2010 Dec; 9(12):1157-1163. PubMed ID: 21059484
[TBL] [Abstract][Full Text] [Related]
10. Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) group.
De Schryver EL
Cerebrovasc Dis; 2000; 10(2):147-50. PubMed ID: 10686454
[TBL] [Abstract][Full Text] [Related]
11. Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry.
Krittayaphong R; Boonyapiphat T; Wongvipaporn C; Sairat P;
Clin Interv Aging; 2021; 16():707-719. PubMed ID: 33953549
[TBL] [Abstract][Full Text] [Related]
12. Echocardiography in patients with symptomatic intracranial stenosis.
Kasner SE; Lynn MJ; Jackson BP; Pullicino PM; Chimowitz MI;
J Stroke Cerebrovasc Dis; 2007; 16(5):216-9. PubMed ID: 17845919
[TBL] [Abstract][Full Text] [Related]
13. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.
Easton JD; Lopes RD; Bahit MC; Wojdyla DM; Granger CB; Wallentin L; Alings M; Goto S; Lewis BS; Rosenqvist M; Hanna M; Mohan P; Alexander JH; Diener HC;
Lancet Neurol; 2012 Jun; 11(6):503-11. PubMed ID: 22572202
[TBL] [Abstract][Full Text] [Related]
14. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?
Hankey GJ; Slattery JM; Warlow CP
J Neurol Neurosurg Psychiatry; 1992 Aug; 55(8):640-52. PubMed ID: 1527533
[TBL] [Abstract][Full Text] [Related]
15. Is the long-term prognosis of transient ischemic attack or minor ischemic stroke affected by the occurrence of nonfocal symptoms?
Compter A; van der Worp HB; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Stroke; 2014 May; 45(5):1318-23. PubMed ID: 24652304
[TBL] [Abstract][Full Text] [Related]
16. Long term risks of stroke, myocardial infarction, and vascular death in "low risk" patients with a non-recent transient ischaemic attack.
Clark TG; Murphy MF; Rothwell PM
J Neurol Neurosurg Psychiatry; 2003 May; 74(5):577-80. PubMed ID: 12700296
[TBL] [Abstract][Full Text] [Related]
17. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable.
Connolly SJ; Eikelboom JW; Ng J; Hirsh J; Yusuf S; Pogue J; de Caterina R; Hohnloser S; Hart RG;
Ann Intern Med; 2011 Nov; 155(9):579-86. PubMed ID: 22041946
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
[TBL] [Abstract][Full Text] [Related]
19. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial.
Diener HC; Eikelboom J; Connolly SJ; Joyner CD; Hart RG; Lip GY; O'Donnell M; Hohnloser SH; Hankey GJ; Shestakovska O; Yusuf S;
Lancet Neurol; 2012 Mar; 11(3):225-31. PubMed ID: 22305462
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
